Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital


  • Siteman Cancer Center is the only center in the state of Missouri to be designated a Comprehensive Cancer Center by the National Cancer Institute (NCI)
  • Siteman is one of the few cancer centers in the U.S. to receive the highest rating of the National Cancer Institute – “exceptional”
  • Siteman offers the expertise of more than 450 Washington University research scientists and physicians who provide care for nearly 9,000 newly diagnosed cancer patients each year.
  • Patients have access to 500 therapeutic clinical trials, including collaborative efforts with other leading cancer centers throughout the country
  • Siteman Cancer Center offers an outreach program of cancer screening and education that impacts tens of thousands of individuals annually 

For more information, please visit the Alvin J. Siteman Cancer Center website.


Net proceeds benefit the Director’s Discovery Fund and the Mike and Judy Shannon Brain Cancer Research Fund.

Cureiosity Beneficiary –
The Director's Discovery Fund

The Alvin J. Siteman Cancer Center is changing the face of cancer through new technologies and personalized medicine. The Discovery Fund allows Dr. Timothy J. Eberlein, Director, to support promising new areas of research for all types of cancer, providing immediate impact on the lives of cancer patients and their families.

The Mike and Judy Shannon Brain Cancer Research Fund

Few diseases are more challenging than brain cancer. The sensitivity of the brain and the complexity of the disease make it difficult to treat. However, researchers at Siteman Cancer Center report that brain cancer research is gaining momentum due to cancer genomics — studying a patient’s DNA. Cancer originates from a genetic mutation, so studying the over-expressed genes in a tumor cell can lead to better understanding and personalized treatment.